Non-inferiority comparative clinical trial between early oral REFEEDING and usual oral REFEEDING in predicted mild acute biliary pancreatitis

Table 2 Comparison of outcome variables between the two groups

Variable	EOR n = 61	UOR n = 59	p
Lipase (0 h) IU/L	547.1 (245–760)	530 (240–840)	0.644^a
Lipase IU/L after oral refeding	485 (174–530)	110 (85–200)	0.665^a
Leukocytes (0 h) 10³UL	10.2 (7.29–13.7)	10.3 (7.8–14)	0.622^a
Leukocytes after oral refeeding 10³UL	10.8 (7–13.2)	7.2 (7–13.2)	0.658^a
Paín (NAS) (0 h)	9 (6–10)	8 (7–10)	0.812^a
Pain (NAS) After oral refeeding	3 (0–3)	3 (1–4)	0.842^a
Time of evolution(h)	20 (12–24)	23 (14–23)	0.668^a
Nausea or vomiting (0 h)	39 (63.9%)	45 (76.2%)	0.186^b
Nausea or vomiting after oral refeeding	1 (1.6%)	3 (5%)	0.293^b
Pain relapse	2 (3.2%)	4 (6.77%)	0.379^b

^aContinuous variables are presented as the medians and interquartile range and were compared using the Mann-Whitney U-test
^b Data are presented as frequencies and percentages, and comparisons between groups were performed using the χ² test

ISSN: 1471-230X